威高血净：拟85.11亿元收购威高普瑞100%股权

Core Viewpoint - Weigao Blood Purification announced plans to acquire 100% equity of Weigao Purui for approximately 8.511 billion yuan through a share issuance, expanding its business into the development, production, and sales of pre-filled drug delivery systems and automatic safety drug delivery systems [1] Group 1 - The transaction involves purchasing shares from three parties: Weigao Co., Weihai Shengxi, and Weihai Ruiming [1] - The share issuance price is set at 31.29 yuan per share [1] - Upon completion of the transaction, Weigao Purui will become a wholly-owned subsidiary of Weigao Blood Purification [1]